Prescribers should initially start patients on a closely monitored 60-day trial to ensure tolerability and screen for adverse side effects. For pharmacologically treated diabetic patients wishing to start glucosamine sulfate supplementation, the Arthritis Foundation recommends an increase in the frequency of blood glucose monitoring due to the theoretical risk of hyperglycemia.